BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
0.358
+0.014 (4.07%)
At close: Jan 21, 2025, 4:00 PM
0.360
+0.002 (0.56%)
After-hours: Jan 21, 2025, 7:37 PM EST
BTAI's stock price has decreased by -86.07% in the past year and price targets may not have had time to catch up.
BioXcel Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$2.81
Upside
+684.92%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy → Sell Downgrades $7 → $0.25 | Strong Buy → Sell | Downgrades | $7 → $0.25 | -30.17% | Jan 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $7 → $5 | Strong Buy | Maintains | $7 → $5 | +1,296.65% | Jan 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $5 | Strong Buy | Maintains | $7 → $5 | +1,296.65% | Oct 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +1,855.31% | Sep 6, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $7 | Strong Buy | Maintains | $7 | +1,855.31% | Aug 30, 2024 |
| UBS | UBS | Hold Maintains $3.5 → $1 | Hold | Maintains | $3.5 → $1 | +179.33% | Aug 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $7 | Strong Buy | Maintains | $10 → $7 | +1,855.31% | Aug 8, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $7 | Strong Buy | Maintains | $7 | +1,855.31% | Jun 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +2,693.30% | May 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +2,693.30% | Apr 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +2,972.63% | Mar 18, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $18 → $7 | Strong Buy | Maintains | $18 → $7 | +1,855.31% | Mar 14, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | +1,855.31% | Mar 13, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades $9 → $4 | Strong Buy → Hold | Downgrades | $9 → $4 | +1,017.32% | Feb 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +2,972.63% | Nov 15, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +2,972.63% | Oct 31, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.